NEWS

NEWS

Total 101

81
News Update NeoImmuneTech and NIAID Embark on a Collaborative Study to Explore New Treatment for Acute Radiation Syndrome (ARS)
2023-06-20
80
Quarterly update QUARTERLY UPDATE (Q1 2023)
2023-04-05
79
News Update First Patient Dosed in Phase II Study of NeoImmuneTech’s NT-I7 plus Pembrolizumab in Recurrent Glioblastoma
2023-02-07
78
Quarterly update QUARTERLY UPDATE (Q4 2022)
2023-01-06
77
Press Release NeoImmuneTech to Partner with U.S. National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) for Drug Development in Acute Radiation Syndrome (ARS)
2023-01-03
76
News Update Pharmaphorum highlights NeoImmuneTech
2022-12-19
75
News Update NeoImmuneTech to Present at 2023 Biotech Showcase
2022-12-15
74
Press Release New evidence of NeoImmuneTech’s NT-I7 clinical efficacy in combination with pembrolizumab in relapsed/refractory (r/r) gastrointestinal tumors
2022-11-14
73
Press Release NeoImmuneTech to Present First Data on NT-I7 (efineptakin alfa) in Combination with CAR-T tisagenlecleucel, at 2022 ASH Annual Meeting
2022-11-04
72
News Update NeoImmuneTech Joins the United Nations Global Compact
2022-10-11

1 2 3 4 5 >>>